(SSSS) SuRo Capital - Overview

Sector: Financial Services | Industry: Asset Management | Exchange: NASDAQ (USA) | Market Cap: 274m USD | Total Return: 174.4% in 12m

Venture Capital, Growth Capital, Private Equity, Investments
Total Rating 58
Safety 66
Buy Signal 1.83
Asset Management
Industry Rotation: +5.5
Market Cap: 274M
Avg Turnover: 2.52M USD
ATR: 4.82%
Peers RS (IBD): 96.6
Risk 5d forecast
Volatility87.8%
Rel. Tail Risk-24.6%
Reward TTM
Sharpe Ratio2.33
Alpha123.90
Character TTM
Beta1.251
Beta Downside1.944
Drawdowns 3y
Max DD33.03%
CAGR/Max DD1.45
EPS (Earnings per Share) EPS (Earnings per Share) of SSSS over the last years for every Quarter: "2021-03": 4.5, "2021-06": 1.32, "2021-09": 0.55, "2021-12": -0.59, "2022-03": 0.66, "2022-06": -3.08, "2022-09": -1.54, "2022-12": -0.43, "2023-03": 0.16, "2023-06": -0.6, "2023-09": 0.99, "2023-12": -0.37, "2024-03": -0.87, "2024-06": -0.45, "2024-09": -0.23, "2024-12": -0.1597, "2025-03": -0.16, "2025-06": 2.23, "2025-09": -0.14, "2025-12": -0.22,
EPS CAGR: -6.82%
EPS Trend: 33.2%
Last SUE: 0.00
Qual. Beats: 0
Revenue Revenue of SSSS over the last years for every Quarter: 2021-03: 0.291352, 2021-06: 0.27482, 2021-09: 0.523916, 2021-12: 0.380754, 2022-03: 0.5831, 2022-06: 0.890631, 2022-09: 0.51951, 2022-12: 1.462951, 2023-03: 1.299082, 2023-06: 1.372218, 2023-09: 1.465746, 2023-12: 2.459734, 2024-03: 1.528091, 2024-06: 1.027353, 2024-09: 0.888717, 2024-12: 1.229266, 2025-03: 0.499094, 2025-06: 0.167304, 2025-09: 5.656068, 2025-12: 7.387387,
Rev. CAGR: 96.82%
Rev. Trend: 27.6%
Last SUE: 4.00
Qual. Beats: 2

Warnings

Share dilution 20.4% YoY - potential capital distress

Tailwinds

No distinct edge detected

Description: SSSS SuRo Capital

SuRo Capital Corp. (SSSS) is a Business Development Company (BDC) that invests in late-stage, venture-backed private companies. BDCs are regulated investment companies that provide capital to small and mid-sized companies.

The firm focuses on growth capital investments across sectors such as technology, media, communication, energy, and consumer. Venture capital firms typically invest in companies with high growth potential.

Geographically, SuRo Capital Corp. targets investments in the United States and Canada. The company exclusively seeks minority equity stakes in its portfolio companies.

For more detailed financial analysis and performance metrics, further research on platforms like ValueRay is recommended.

Headlines to Watch Out For
  • Venture capital investment performance impacts portfolio valuation
  • Exits from private companies drive realized gains
  • Investment in technology and media sectors influences returns
  • Interest rate changes affect cost of capital
Piotroski VR‑10 (Strict) 2.5
Net Income: 48.8m TTM > 0 and > 6% of Revenue
FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.54 > 1.0
NWC/Revenue: 109.6m% < 20% (prev 429.2%; Δ 109.6m% < -1%)
CFO/TA -0.00 > 3% & CFO -16.2m > Net Income 48.8m
Current Ratio: 1.44 > 1.5 & < 3
Outstanding Shares: last quarter (28.8m) vs 12m ago 20.45% < -2%
Gross Margin: 62.89% > 18% (prev -0.04%; Δ 6.29k% > 0.5%)
Asset Turnover: 0.00% > 50% (prev 2.02%; Δ -2.02% > 0%)
Interest Coverage Ratio: 1.71 > 6 (EBITDA TTM 53.7m / Interest Expense TTM 5.09m)
Altman Z'' 0.36
A: 0.05 (Total Current Assets 49152.86b - Total Current Liabilities 34131.51b) / Total Assets 276018.72b
B: -0.00 (Retained Earnings -3.97m / Total Assets 276018.72b)
C: 0.00 (EBIT TTM 8.69m / Avg Total Assets 138009.48b)
D: 0.00 (Book Value of Equity 253.77b / Total Liabilities 70702.47b)
Altman-Z'' Score: 0.36 = B
What is the price of SSSS shares? As of April 08, 2026, the stock is trading at USD 11.72 with a total of 868,431 shares traded.
Over the past week, the price has changed by +9.43%, over one month by +28.23%, over three months by +23.76% and over the past year by +174.43%.
Is SSSS a buy, sell or hold? SuRo Capital has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy SSSS.
  • StrongBuy: 2
  • Buy: 2
  • Hold: 0
  • Sell: 0
  • StrongSell: 0
What are the forecasts/targets for the SSSS price?
Analysts Target Price 13.3 13.5%
SuRo Capital (SSSS) - Fundamental Data Overview as of 06 April 2026
P/E Trailing = 6.0618
P/E Forward = 0.7198
P/S = 162.4469
P/B = 1.3351
Revenue TTM = 13.7m USD
EBIT TTM = 8.69m USD
EBITDA TTM = 53.7m USD
 Long Term Debt = unknown (0.0)
 Short Term Debt = 34131.51b USD (from shortTermDebt, last quarter)
Debt = 34131.51b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -14902.65b USD (from netDebt column, last quarter)
Enterprise Value = 273.9m USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 1.71 (Ebit TTM 8.69m / Interest Expense TTM 5.09m)
EV/FCF = 0.00x (Enterprise Value 273.9m / FCF TTM 4301.46b)
 FCF Yield = 1.57m% (FCF TTM 4301.46b / Enterprise Value 273.9m)
 FCF Margin = 31.4m% (FCF TTM 4301.46b / Revenue TTM 13.7m)
 Net Margin = 356.0% (Net Income TTM 48.8m / Revenue TTM 13.7m)
 Gross Margin = 62.89% ((Revenue TTM 13.7m - Cost of Revenue TTM 5.09m) / Revenue TTM)
Gross Margin QoQ = 82.73% (prev 77.43%)
Tobins Q-Ratio = 0.00 (Enterprise Value 273.9m / Total Assets 276018.72b)
Interest Expense / Debt = 0.00% (Interest Expense 1.28m / Debt 34131.51b)
Taxrate = 21.0% (US default 21%)
NOPAT = 6.87m (EBIT 8.69m * (1 - 21.00%))
Current Ratio = 1.44 (Total Current Assets 49152.86b / Total Current Liabilities 34131.51b)
Debt / Equity = 0.17 (Debt 34131.51b / totalStockholderEquity, last quarter 205316.25b)
 Debt / EBITDA = -277k (out of range, set to none) (Net Debt -14902.65b / EBITDA 53.7m)
 Debt / FCF = -3.46 (Net Debt -14902.65b / FCF TTM 4301.46b)
Total Stockholder Equity = 51329.21b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.00% (Net Income 48.8m / Total Assets 276018.72b)
RoE = 0.00% (Net Income TTM 48.8m / Total Stockholder Equity 51329.21b)
RoCE = 0.00% (EBIT 8.69m / Capital Employed (Equity 51329.21b + L.T.Debt 0.0))
RoIC = 2.49% (NOPAT 6.87m / Invested Capital 275.8m)
WACC = 0.00% (E(273.9m)/V(34131.78b) * Re(10.38%) + D(34131.51b)/V(34131.78b) * Rd(0.00%) * (1-Tc(0.21)))
Discount Rate = 10.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 6.80%
[DCF] Terminal Value 80.82% ; FCFF base≈2580.88b ; Y1≈1694.47b ; Y5≈774.89b
[DCF] Fair Price = 1.56m (EV 24596.98b - Net Debt -14902.65b = Equity 39499.63b / Shares 25.4m; r=6.0% [WACC]; 5y FCF grow -40.0% → 3.0% )
 [DCF] Fair Price = 1.56m (out of range, set to none)
 EPS Correlation: 33.16 | EPS CAGR: -6.82% | SUE: 0.00 | # QB: 0
Revenue Correlation: 27.56 | Revenue CAGR: 96.82% | SUE: 4.0 | # QB: 2
EPS next Quarter (2026-06-30): EPS=-0.15 | Chg7d=-0.015 | Chg30d=-0.015 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=-0.67 | Chg7d=-0.015 | Chg30d=-0.015 | Revisions Net=+0 | Growth EPS=+0.0% | Growth Revenue=-3.8%
EPS next Year (2027-12-31): EPS=-0.72 | Chg7d=-0.080 | Chg30d=-0.080 | Revisions Net=-1 | Growth EPS=-8.3% | Growth Revenue=+0.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -6.1% (Discount Rate 10.4% - Earnings Yield 16.5%)
[Growth] Growth Spread = +148.5% (Analyst 142.4% - Implied -6.1%)
External Resources